Advertisement
UK markets open in 1 hour 39 minutes

  • NIKKEI 225

    38,392.33
    +840.17 (+2.24%)
     

  • HANG SENG

    17,139.09
    +310.16 (+1.84%)
     

  • CRUDE OIL

    83.48
    +0.12 (+0.14%)
     

  • GOLD FUTURES

    2,338.10
    -4.00 (-0.17%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,683.69
    +477.29 (+0.90%)
     

  • CMC Crypto 200

    1,443.85
    +29.09 (+2.06%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

These 10 Drug Companies are Testing a Coronavirus Vaccine

Madeleine Johnson

As the coronavirus pandemic continues to spread, some of the biggest drug companies are moving closer to finding a vaccine.

Biotech giant Gilead Sciences GILD is planning to administer its remdesivir drug to patients this month. Remdesivir is an experimental drug that has been used to treat Ebola in the past. The World Health Organization (WHO) believes it may be the best chance to effectively treat COVID-19.

Novavax NVAX and Moderna MRNA are also working on vaccines; both companies expect to begin phase 1 studies soon.

Inovio Pharmaceuticals INO is prepping a DNA-based vaccine for U.S. clinical trials in April, while drugmaker Sanofi SNY has also recently announced plans to develop a vaccine. It said it will leverage previous work for a SARS pre-clinical vaccine.

ADVERTISEMENT

Takeda Pharmaceutical Co. TAK, Regeneron Pharmaceuticals REGN, & Vir Biotechnology VIR have all announced development on preclinical treatments, and other large drugmakers like GlaxoSmithKline GSK and Johnson & Johnson JNJ are working on vaccines too.

Scientists are hoping to cut the time it takes to develop a vaccine in half and have a viable vaccine by this fall. As of today, more than 183,000 have been confirmed globally, with at least 7,167 deaths, according to John Hopkins University. Here in the U.S., there are at least 4,661 cases and 85 deaths.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Johnson & Johnson (JNJ) : Free Stock Analysis Report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Sanofi (SNY) : Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
GlaxoSmithKline plc (GSK) : Free Stock Analysis Report
 
Novavax, Inc. (NVAX) : Free Stock Analysis Report
 
Inovio Pharmaceuticals, Inc. (INO) : Free Stock Analysis Report
 
Vir Biotechnology, Inc. (VIR) : Free Stock Analysis Report
 
Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research